"To Be Honest, You Probably Would Have to Read It 50 Times": Stakeholders Views on Using the Opt-Out Approach for Vaccination in Jails.

infectious diseases testing infectious diseases vaccination opt-out approach opt-out testing opt-out vaccination

Journal

Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045

Informations de publication

Date de publication:
May 2023
Historique:
received: 23 01 2023
accepted: 17 04 2023
medline: 18 5 2023
pubmed: 18 5 2023
entrez: 17 5 2023
Statut: epublish

Résumé

Despite national guidelines on infectious disease testing and vaccination in prisons, there is heterogeneity on the implementation of these practices in jails. We sought to better understand perspectives on the implementation of opt-out vaccination for infectious diseases in jails by interviewing a broad group of stakeholders involved in infectious diseases vaccination, testing, and treatment in Massachusetts jails. The research team conducted semistructured interviews with people incarcerated in Hampden County Jail (Ludlow, Massachusetts), clinicians working in jail and community settings, corrections administrators, and representatives from public health, government, and industry between July 2021 and March 2022. Forty-eight people were interviewed, including 13 people incarcerated at the time of interview. Themes that emerged included the following: misunderstandings of what opt-out means, indifference to the way vaccines are offered, belief that using the opt-out approach will increase the number of individuals who receive vaccination, and that opt-out provides an easy way for vaccine rejection and reluctance to accept vaccination. There was a clear divide in stakeholders' support of the opt-out approach, which was more universally supported by those who work outside of jails compared to those who work within or are incarcerated in jails. Compiling the perspectives of stakeholders inside and outside of jail settings on the opt-out approach to vaccination is the first step to develop feasible and effective strategies for implementing new health policies in jail settings.

Sections du résumé

Background UNASSIGNED
Despite national guidelines on infectious disease testing and vaccination in prisons, there is heterogeneity on the implementation of these practices in jails. We sought to better understand perspectives on the implementation of opt-out vaccination for infectious diseases in jails by interviewing a broad group of stakeholders involved in infectious diseases vaccination, testing, and treatment in Massachusetts jails.
Methods UNASSIGNED
The research team conducted semistructured interviews with people incarcerated in Hampden County Jail (Ludlow, Massachusetts), clinicians working in jail and community settings, corrections administrators, and representatives from public health, government, and industry between July 2021 and March 2022.
Results UNASSIGNED
Forty-eight people were interviewed, including 13 people incarcerated at the time of interview. Themes that emerged included the following: misunderstandings of what opt-out means, indifference to the way vaccines are offered, belief that using the opt-out approach will increase the number of individuals who receive vaccination, and that opt-out provides an easy way for vaccine rejection and reluctance to accept vaccination.
Conclusions UNASSIGNED
There was a clear divide in stakeholders' support of the opt-out approach, which was more universally supported by those who work outside of jails compared to those who work within or are incarcerated in jails. Compiling the perspectives of stakeholders inside and outside of jail settings on the opt-out approach to vaccination is the first step to develop feasible and effective strategies for implementing new health policies in jail settings.

Identifiants

pubmed: 37197230
doi: 10.1093/ofid/ofad212
pii: ofad212
pmc: PMC10184438
doi:

Types de publication

Journal Article

Langues

eng

Pagination

ofad212

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Déclaration de conflit d'intérêts

Potential conflicts of interest. CGB received grant and research support from Gilead Sciences, Inc. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Références

Am J Epidemiol. 1994 Jul 15;140(2):113-22
pubmed: 8023800
Soc Sci Med. 2022 Aug;307:115120
pubmed: 35792410
Vaccine. 2006 Feb 27;24(9):1354-8
pubmed: 16297510
AIDS Patient Care STDS. 2008 Mar;22(3):189-93
pubmed: 18290754
AIDS Rev. 2017 Oct-Dec;19(3):134-147
pubmed: 28926560
PLoS One. 2021 May 26;16(5):e0250901
pubmed: 34038430
Am J Public Health. 2021 May;111(5):776-777
pubmed: 33826375
Clin Infect Dis. 2023 Feb 8;76(3):e1416-e1420
pubmed: 35959718
Am J Public Health. 2021 May;111(5):839-841
pubmed: 33734843
Epidemiol Infect. 1996 Dec;117(3):485-92
pubmed: 8972673
MMWR Morb Mortal Wkly Rep. 2021 Feb 26;70(8):269-272
pubmed: 33630818
Hum Vaccin Immunother. 2016 Jun 2;12(6):1566-88
pubmed: 26838959
Int J Forensic Ment Health. 2013 Apr 1;12(2):116-125
pubmed: 24039547
Health Serv Res. 2007 Aug;42(4):1758-72
pubmed: 17286625
J Acquir Immune Defic Syndr. 2018 Jun 1;78(2):214-220
pubmed: 29474267
JAMA Pediatr. 2017 Sep 1;171(9):893-896
pubmed: 28672396
Epidemiol Infect. 2018 Oct;146(13):1689-1691
pubmed: 30021664
Int J Environ Res Public Health. 2020 Feb 14;17(4):
pubmed: 32075182
Vaccine. 2022 May 11;40(22):2981-2983
pubmed: 35440414
MMWR Morb Mortal Wkly Rep. 2020 Jul 03;69(26):820-824
pubmed: 32614812
Int J Gynaecol Obstet. 2021 Dec;155(3):549-550
pubmed: 34529276
Ann Intern Med. 2016 Jan 19;164(2):84-92
pubmed: 26595252
Implement Sci. 2017 Jun 21;12(1):77
pubmed: 28637486
Am J Public Health. 2021 Jun;111(6):1035-1039
pubmed: 33950714
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
Vaccine. 2019 Mar 7;37(11):1412-1417
pubmed: 30733091
J Urban Health. 2001 Jun;78(2):304-12
pubmed: 11419583
J Correct Health Care. 2014 Jun 16;20(3):228-239
pubmed: 24934841
Sex Transm Dis. 2013 Oct;40(10):776-83
pubmed: 24275727
J Correct Health Care. 2019 Jul;25(3):277-286
pubmed: 31242806
Am J Public Health. 2016 Dec;106(12):2231-2237
pubmed: 27631758
MMWR Morb Mortal Wkly Rep. 2016 Jan 29;65(3):47-50
pubmed: 26821369
J Correct Health Care. 2021 Dec;27(4):265-271
pubmed: 34724807
J Gen Intern Med. 2012 Aug;27(8):985-91
pubmed: 22528615
BMC Health Serv Res. 2019 Mar 08;19(1):152
pubmed: 30849986
Sex Transm Dis. 2009 Feb;36(2 Suppl):S58-61
pubmed: 17989586

Auteurs

Laura Lodolo (L)

Tufts University School of Medicine, Boston, Massachusetts, USA.

Emma Smyth (E)

Division of Geographic Medicine and Infectious Diseases, Department of Medicine, Tufts Medical Center, Boston, Massachusetts, USA.

Yvane Ngassa (Y)

Division of Geographic Medicine and Infectious Diseases, Department of Medicine, Tufts Medical Center, Boston, Massachusetts, USA.

Bridget Pickard (B)

Division of Geographic Medicine and Infectious Diseases, Department of Medicine, Tufts Medical Center, Boston, Massachusetts, USA.

Amy M LeClair (AM)

Tufts University School of Medicine, Boston, Massachusetts, USA.
Division of Geographic Medicine and Infectious Diseases, Department of Medicine, Tufts Medical Center, Boston, Massachusetts, USA.

Curt G Beckwith (CG)

Division of Infectious Diseases, Alpert Medical School of Brown University/The Miriam Hospital, Providence, Rhode Island, USA.

Alysse Wurcel (A)

Tufts University School of Medicine, Boston, Massachusetts, USA.
Division of Geographic Medicine and Infectious Diseases, Department of Medicine, Tufts Medical Center, Boston, Massachusetts, USA.

Classifications MeSH